EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSLOCG00000009977
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSLOCG00000009990
Gene Symbol: TLR8
2 Cross references
199 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSLOCG00000009982
Gene Symbol: TLR8
4 Cross references
199 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSLOCG00000018220
Gene Symbol: TLR2
1 Cross references
241 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLOCG00000017887
Gene Symbol: LOC102689651
3 Cross references
149 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLOCG00000017288
Gene Symbol: LOC102689850
2 Cross references
123 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSLOCG00000010673
Gene Symbol: TGFBR1
3 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSLOCG00000003830
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSLOCG00000006755
Gene Symbol: TPH1
3 Cross references
256 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSLOCG00000004153
Gene Symbol: TUBA1C
2 Cross references
120 Possible Orthologues:

Tubulin Alpha 3e

Ensembl ID : ENSLOCG00000014394
Gene Symbol: TUBA3E
2 Cross references
316 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSLOCG00000010681
Gene Symbol: LOC102695089
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).